Not a Member?
Email this page
Send the page ""
to a friend, relative, colleague or yourself.
Separate multiple email address with a comma
We do not record any personal information entered above.
Thank you. Your email has been sent.
Goal of the Mycophenolate REMS Program
The goal of the Mycophenolate REMS is to mitigate the risk of embryofetal toxicity associated with use of mycophenolate during pregnancy by:
1. Educating healthcare providers on the following:• The increased risks of first trimester pregnancy loss and congenital malformations associated with exposure to mycophenolate during pregnancy.• The need to counsel females of reproductive potential on the importance of pregnancy prevention and planning when taking mycophenolate.• The need to report pregnancies to the Mycophenolate Pregnancy Registry.
2. Informing females of reproductive potential who are prescribed mycophenolate about:• The increased risks of first trimester pregnancy loss and congenital malformations when taking mycophenolate during pregnancy.• The importance of pregnancy prevention and planning when taking mycophenolate.
• Elements to Assure Safe Use